WallStreetZenWallStreetZen

NASDAQ: TSHA
Taysha Gene Therapies Inc Stock Ownership - Who owns Taysha Gene Therapies?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Taysha Gene Therapies Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Kamran AlamCHIEF FINANCIAL OFFICER2026-02-041,655$4.52
$7.48kSell
Sean P. NolanChief Executive Officer2026-01-2641,312$4.61
$190.45kSell
Sukumar NagendranPresident and Head of RD2026-01-2626,918$4.61
$124.09kSell
Kamran AlamCHIEF FINANCIAL OFFICER2026-01-2623,849$4.61
$109.94kSell
Kamran AlamCHIEF FINANCIAL OFFICER2026-01-2378,968$4.75
$375.10kSell
Sean P. NolanChief Executive Officer2026-01-23136,789$4.75
$649.75kSell
Sukumar NagendranPresident and Head of RD2026-01-2389,132$4.75
$423.38kSell
Sukumar NagendranPresident and Head of RD2026-01-1288,676$1.71
$151.64kBuy
Sukumar NagendranPresident and Head of RD2026-01-12111,324$0.70
$77.82kBuy
Sukumar NagendranPresident and Head of RD2026-01-12200,000$4.71
$942.00kSell

1 of 3

TSHA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TSHA insiders and whales buy or sell their stock.

TSHA Shareholders

What type of owners hold Taysha Gene Therapies Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc6.81%18,643,129$84.83MInstitution
Morgan Stanley6.60%18,078,518$82.26MInstitution
Goldman Sachs Group Inc5.00%13,692,739$62.30MInstitution
Vanguard Group Inc4.84%13,267,805$60.37MInstitution
State Street Corp3.94%10,790,084$49.09MInstitution
Siren LLC3.70%10,129,913$46.09MInstitution
Ra Session Ii3.29%9,012,837$41.01MInsider
Audentes Therapeutics Inc2.65%7,266,342$33.06MInsider
Barclays PLC2.02%5,539,001$25.20MInstitution
Geode Capital Management LLC1.97%5,387,026$24.51MInstitution

1 of 3

TSHA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TSHA44.32%11.62%Net BuyingNet Selling
EYPT16.62%83.38%Net SellingNet Selling
NBTX11.74%0.00%
DAWN44.85%55.15%Net Selling
BHVN54.24%22.37%Net BuyingNet Selling
View Top Biotech Stocks

Taysha Gene Therapies Stock Ownership FAQ

Who owns Taysha Gene Therapies?

Taysha Gene Therapies (NASDAQ: TSHA) is owned by 44.32% institutional shareholders, 11.62% Taysha Gene Therapies insiders, and 44.06% retail investors. Ra Session Ii is the largest individual Taysha Gene Therapies shareholder, owning 9.01M shares representing 3.29% of the company. Ra Session Ii's Taysha Gene Therapies shares are currently valued at $41.28M.

If you're new to stock investing, here's how to buy Taysha Gene Therapies stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.